The putative somatostatin antagonist, cyclo-(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[BZL]), may act as potent antiproliferative agonist

Peptides

Volumn 23, Issue 8, 2002, Pages 1503-1506

  Stirnweis, Jörg ^a   Boehmer, Frank D ^a   Liebmann, Claus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cell growth inhibition; MAP kinase; Protein tyrosine phosphatase; Somatostatin antagonist

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPEPTIDE; HORMONE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

AGONIST; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

DNA; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROBLASTOMA; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 0036701377     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00089-X     Document Type: Article

References (10)

1. Borgstrom P., Hassan M., Wassberg E., Refai E., Jonsson C., Larsson S.A.et al. The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo. Pediatr. Res. 46:1999;328-332.
2. Douziech N., Calvo E., Coulombe Z., Muradia G., Bastien J., Aubin R.A.et al. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1. Endocrinology. 140:1999;765-777.
3. 2 receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist. Br. J. Pharmacol. 131:2000;1553-1560.
4. Florio T., Yao H., Carey K.T., Dillon T.J., Stork P.J. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). Mol. Endocrinol. 13:1999;24-37.
5. Fries J.L., Murphy W.A., Sueiras-Diaz J., Coy D.H. Somatostatin antagonist anaolg increases GH, insulin, and glucagon release in the rat. Peptides. 3:1982;811-814.
6. Graness A., Hanke S., Boehmer F.D., Presek P., Liebmann C. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Biochem. J. 347:2000;441-447.
7. 2+ channels. J. Neurosci. 10:1990;2687-2698.
8. Liebmann C. Regulation of MAP kinase activity by peptide receptor signalling pathways: paradigms of multiplicity. Cell. Signal. 13:2001;777-785.
9. Smedh U., Kaplan J.M., Uvnas-Moberg K. Corticotropin-releasing factor-induced suppression of gastric emptying in the rat is blocked by cyclo(7-aminoheptanoyl-phe-D-TRP-LYS-THR[BZL], an in vivo somatostatin antagonist. Neurosci. Lett. 260:1999;41-44.
10. Tamaoki J., Tagaya E., Yamauchi F., Chiyotani A., Konno K. Pertussis toxin-sensitive airway beta-adrenergic dysfunction by somatostatin. Resp. Physiol. 95:1994;99-108.